iRhythm Technologies (Nasdaq:IRTC) announced today that it appointed a new chief financial officer and a new chief human resources officer. The San Francisco-based wearable electrocardiogram monitors developer will bring in Brice Bobzien as CFO and Reyna Fernandez as EVP and chief human resources officer (CHRO). Fernandez’s appointment was made effective today, while Bobzien will join […]
Patient Monitoring
FDA clears iRhythm’s ZEUS system for Zio Watch
iRhythm Technologies (Nasdaq:IRTC) announced today that it received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) system. ZEUS, produced in partnership with Google’s life sciences sister company Verily, combines deep-learned algorithms with iRhythm’s cardiac arrhythmia service, providing the AI algorithm component for the Zio Watch sensor-based wearable for non-invasive, clinical-grade, long-term continuous monitoring […]
ArchiMed completes $1.2B acquisition of Natus Medical
Natus Medical (Nasdaq:NTUS) announced today that ArchiMed’s investment firm completed its previously announced acquisition of the company. In April, the company announced that the MED Platform II fund of ArchiMed — an investment firm focused on the healthcare industry — would acquire Natus, a developer of medical devices for screening, diagnosing and treating disorders affecting […]
Study backs Masimo’s SedLine for guiding anesthesia
Masimo (Nasdaq:MASI) announced today that the findings of a trial support the use of its SedLine brain function monitoring. Results from the randomized, controlled trial were published in the Journal of Clinical Anesthesia. In the trial, Dr. Melody H.Y. Long and colleagues from the KK Women’s and Children’s Hospital in Singapore evaluated the ability of electroencephalogram (EEG)-guided […]
Zillion partners with Dexcom on CGM integration
Zillion announced today that it partnered with Dexcom (Nasdaq:DXCM) to integrate its CGM technology with Zillion’s digital health platform. Needham, Massachusetts-based Zillion will connect Dexcom’s continuous glucose monitoring (CGM) platform with its digital health offering for the RestoreHealth program, enhancing RestoreHealth for employer and health system patients. Get the full story at our sister site, […]
Senseonics announces equity grants to employees
Senseonics (NYSE:SENS) announced that it made equity grants to new employees under its 2019 inducement plan. Germantown, Maryland–based Senseonics, which develops the Eversense family continuous glucose monitoring (CGM) systems, including the latest-generation Eversense E3 180-day CGM, made the equity grants in accordance with the NYSE American Company Guide Section 711(a). Get the full story at our […]
Masimo’s SafetyNet monitoring reduced length of COVID-19 hospital stays, study says
Masimo (Nasdaq:MASI) announced that a two-part retrospective study demonstrated the impact of its SafetyNet monitoring system. Irvine, California-based Masimo’s study, led by Dr. Hemali Patel and colleagues at the University of Colorado and UC Health (UCH) in Aurora, Colorado, evaluated the impact of remote patient monitoring of COVID-19 patients using SafetyNet on hospital length of […]
Clarius partners with ImaCor on handheld hemodynamic ultrasound tech
Clarius Mobile Health announced today that it partnered with ImaCor to make available a handheld transesophageal echocardiography (TEE) system. According to a news release, the partnership will enable the availability of the world’s first handheld TEE system designed to manage and guide care for critically ill patients in the intensive care unit (ICU). ImaCor designed […]
BioSig expects to raise $3.5M from public offering
BioSig Technologies (Nasdaq:BSGM) announced today that it priced a previously announced public offering at $3.5 million. Westport, Connecticut–based BioSig’s best efforts, underwritten public offering totals up to 4,666,667 shares of its common stock, $0.001 par value per share, at a price to the public of $0.75 per share, bringing the gross proceeds to $3.5 million. […]
GlucoTrack provides positive update on next-gen glucose monitor
GlucoTrack (Nasdaq:GCTK) announced today that its second-generation glucose monitor device has shown promising results in analyses. Rutherford, New Jersey-based GlucoTrack — formerly known as Integrity Applications (Nasdaq:IGAP) — earlier this year completed lab testing of the non-invasive GlucoTrack 2.0 clinical prototype system and has observed better-than-expected accuracy and performance with the technology. Get the full […]
GE Healthcare unveils wireless patient monitoring platform
GE Healthcare (NYSE:GE) today introduced a continuous monitoring platform with wearable sensors for detecting patient deterioration. The technology, aimed to detect deterioration earlier than traditional sampling methods to improve patient outcomes, was developed at GE Healthcare’s global center of excellence for monitoring solutions in Helsinki, Finland. GE Healthcare’s Portrait Mobile platform wirelessly monitors throughout the […]